Nabumetone

Mebutan Dispers 1 g, tabletten

TabletNetherlandsAuthorisedAuthorised 26 Apr 1991

In other countries

The same active substances on other registers, the same brand first.

NabumetoneCanada · 500 MG · Tablet · Aa Pharma INCSame form
NabumetoneCanada · 500 MG · Tablet · Apotex INCSame form
Mylan-NabumetoneCanada · 500 MG · Tablet · Mylan Pharmaceuticals UlcSame form
Relif 1000 MG Comprimidos DispersablesSpain · 1 g · comprimido dispersable · Viatris Healthcare LimitedSame form
NabuserItaly · Compressa rivestita · Pharmaday Pharmaceutical S.R.L. UnipersonaleSame form
NabumetoneUnited States · 1GM, 500MG, 750MG · tablet · Sciegen PharmsSame form
RelafenUnited States · 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Smithkline Beecham

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Nabumetone

Mebutan Dispers 1 g, tabletten

TabletNetherlandsAuthorisedAuthorised 26 Apr 1991

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

RelifexBrazil · Glaxosmithkline Brasil Ltda

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Nabumetone
Dosage form: Tablet
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 26 Apr 1991
Registration: 12603
Marketing authorisation holder: Viatris Healthcare B.V.
ATC code: M01AX01
Group: Musculo-skeletal system
Procedure: National (RVG)
Supply: Uitsluitend recept